News

The average wholesale prices of the originator insulin are around $329 per vial and $510 for five pens ... biosimilar product version of Lantus – Semglee – that is completely interchangeable ...
During his 2023 State of the State tour, Newsom announced California would begin selling insulin for $30 a vial with a “2024 ... The FDA approved Semglee in 2021, the first interchangeable ...
This will allow pharmacy level substitution and thereby provide convenient and affordable access to Semglee, a quality Biosimilar Insulin Glargine.” Biocon Biologics Managing Director Arun ...